10980sek
3,2 %
Date:2025-06-04Time:18:00:00Latest report:Q1-2025List:First NorthTicker:DVYSR
Market Cap:1 818 msekEnterprise Value:1 761 msekNet Sales:220,9 msekEarnings:-69,8 msekEmployees:0ISIN:SE0016588867

Ratios

10-year key figure history for Devyser Diagnostics turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Devyser Diagnostics with index and moving average MA50 and MA200.

Stockprice:109,80
MA50:101,37
MA200:118,46
Price/MA200:-7,3 %
RSI (14):59,9
Price/MA50:8,3 %

Description

Devyser Diagnostics develops, manufactures, and sells genetic tests to laboratories globally. The products are used for DNA tests in oncology, transplantation, and hereditary diseases to enable tailored cancer treatment, diagnosis of a large number of genetic diseases, and follow-up of transplant patients. The company is headquartered in Hägersten.

Medical Equipment